Point72 Asset Management L.P. Takes $13.12 Million Position in Aspen Aerogels, Inc. (NYSE:ASPN)

Point72 Asset Management L.P. acquired a new stake in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 1,104,549 shares of the construction company's stock, valued at approximately $13,122,000. Point72 Asset Management L.P. owned approximately 1.35% of Aspen Aerogels at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. AlphaQuest LLC grew its position in shares of Aspen Aerogels by 54.0% during the 4th quarter. AlphaQuest LLC now owns 11,395 shares of the construction company's stock worth $135,000 after buying an additional 3,998 shares during the period. KLP Kapitalforvaltning AS bought a new position in Aspen Aerogels in the fourth quarter valued at approximately $164,000. Connors Investor Services Inc. acquired a new stake in Aspen Aerogels during the 4th quarter worth $168,000. Journey Strategic Wealth LLC acquired a new stake in Aspen Aerogels during the 4th quarter worth $178,000. Finally, Ballentine Partners LLC raised its position in shares of Aspen Aerogels by 19.2% during the 4th quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company's stock valued at $189,000 after acquiring an additional 2,565 shares during the last quarter. 97.64% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, CEO Donald R. Young purchased 20,000 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The shares were bought at an average price of $5.35 per share, for a total transaction of $107,000.00. Following the completion of the transaction, the chief executive officer now owns 550,856 shares of the company's stock, valued at approximately $2,947,079.60. This trade represents a 3.77% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 4.30% of the company's stock.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Wall Street Zen upgraded shares of Aspen Aerogels to a "sell" rating in a research report on Wednesday, February 19th. Barclays cut their target price on shares of Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating on the stock in a report on Wednesday, February 19th. Craig Hallum reduced their price target on shares of Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating on the stock in a research report on Friday, February 14th. TD Cowen upgraded shares of Aspen Aerogels to a "strong-buy" rating in a research report on Tuesday, March 11th. Finally, B. Riley dropped their price objective on Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating on the stock in a research note on Wednesday, February 19th. One research analyst has rated the stock with a sell rating, two have given a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Aspen Aerogels has a consensus rating of "Moderate Buy" and a consensus target price of $19.11.

Aspen Aerogels Stock Up 5.6%

ASPN stock traded up $0.34 during mid-day trading on Thursday, reaching $6.43. The company had a trading volume of 1,885,136 shares, compared to its average volume of 1,980,456. The company has a market capitalization of $527.94 million, a price-to-earnings ratio of 40.19 and a beta of 2.72. Aspen Aerogels, Inc. has a 52 week low of $4.16 and a 52 week high of $33.15. The stock has a 50 day simple moving average of $5.83 and a two-hundred day simple moving average of $9.89. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The construction company reported ($0.06) EPS for the quarter, beating the consensus estimate of ($0.07) by $0.01. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. The company had revenue of $78.72 million during the quarter, compared to the consensus estimate of $82.75 million. During the same quarter in the prior year, the firm posted ($0.02) EPS. The firm's revenue for the quarter was down 16.7% compared to the same quarter last year. As a group, equities analysts predict that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current fiscal year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.